CTI (Biometrics)
Biometrics / Data Science · Global
Best suited for sponsors wanting biostatistics consulting alongside data management.
Best for: Sponsors wanting biostatistics consulting alongside data management
Editorial ranking
We compare 46 clinical data management vendor vendors on delivery reliability, compliance readiness, data quality and value - independent profiles compiled from public sources, ranked by evidence. Currently leading: CTI (Biometrics), Lambda (Biometrics), Aetion.
Evidence-led comparison
Biometrics / Data Science · Global
Best suited for sponsors wanting biostatistics consulting alongside data management.
Best for: Sponsors wanting biostatistics consulting alongside data management
Biometrics / Data Science · Global
Best suited for cost-conscious sponsors needing biostatistics and data management from india.
Best for: Cost-conscious sponsors needing biostatistics and data management from India
Top choice for sponsors needing regulatory-grade causal analysis of real-world data for submissions and HTA.
Best for: Regulatory RWE submissions, Causal inference analytics, HTA evidence generation, RCT emulation
Biometrics / data science · Global
Best suited for sponsors needing outsourced data science,stats,or programming capacity. official or public sources indicate Algorics Biostatistics offers sponsor-facing biometrics / data science capability relevant to clinical trial procurement.
Best for: Sponsors needing outsourced data science,stats,or programming capacity
Biometrics / data science · Global
Best suited for programmes needing statistics,programming,data management or analytics. public sources indicate Berry Consultants operates in biometrics / data science with a focus on adaptive trial design; bayesian analysis; simulation and a global footprint.
Best for: Programmes needing statistics,programming,data management or analytics
Order follows the CVC evidence model. Scores appear only for vendors with verified reviews; a vendor without reviews is never given a number. Read the methodology.
This guide is for clinical operations leads, data managers and biotech teams choosing a partner to build and run the clinical database for a trial, or reviewing the data management offer inside a CRO proposal. It is also for sponsors whose in-house data team needs extra capacity, or who want independent data management separate from the CRO running the study.
If you are looking for the best data management vendors for clinical trials, treat the vendor cards and table on this page as a starting point, not a verdict. They show which vendors are listed and how each profile describes its focus; they cannot tell you how a team builds a database, cleans data or performs at lock. Use the criteria below to decide what to ask before you commit.
Clinical data management turns what happens at trial sites into a clean, complete and documented database ready for analysis. The work starts before the first patient: writing the data management plan, designing case report forms, building the database in an electronic data capture system, programming edit checks and running user acceptance testing. During the trial, the team reviews data, issues and resolves queries, codes adverse events and medications, and reconciles external data, such as central lab results, electronic patient-reported outcomes and the safety database. At the end it runs the lock process and delivers the database and its documentation.
Data management sits between the EDC technology provider and the biostatistics team. Some vendors offer all three, some only provide services in the sponsor's chosen system, and others combine data management with biostatistics. The vendors on this page are listed in the biometrics and data science category, so many offer data management alongside statistics.
Typical trigger points are a protocol nearing final, a switch away from a CRO's bundled data management, a study with many external data sources, a rescue of a database in difficulty, or a capacity gap in the sponsor's own data team.
Ask which EDC systems the team builds in and how many studies it has built in each. If the vendor supplies its own system, ask about licensing, data export and what happens at the end of the contract. If you own the system, ask how the vendor works inside your environment and who controls access.
Ask whether the vendor has a library of standard forms aligned with CDASH, how it maps collected data to SDTM, and how it documents specifications. Ask how user acceptance testing is planned and who signs it off. A disciplined build reduces the post-production changes that are expensive once patients are enrolled.
Ask for the data review plan: which checks run automatically, which are manual listings, how often data are reviewed, and how queries are prioritised. Excessive low-value queries frustrate site staff and slow the study, so ask how the vendor keeps query volume proportionate to risk.
Modern trials bring data from many sources. Ask how the vendor agrees data transfer specifications with labs, imaging, eCOA and randomisation providers, how often it runs test transfers, and how it reconciles serious adverse events between the clinical and safety databases.
Ask who performs coding, which dictionaries and versions are used, and how coding is reviewed by a medically qualified person. Consistent coding underpins safety reporting and the integrated safety analyses in a submission.
ICH E6(R3) expects sponsors to focus oversight on the data and processes that matter most. Ask how the vendor identifies critical data, whether it uses central statistical monitoring to look for unusual patterns across sites, and how findings are fed back to the monitoring team.
Ask how systems are validated, how audit trails are reviewed, and how the vendor meets 21 CFR Part 11 and the EMA guideline on computerised systems and electronic data in clinical trials. Ask how personal data are protected under GDPR when data move between countries.
Sponsors sometimes change data management vendor mid-study, after an acquisition, a CRO change or a database in difficulty. Transitions are risky: specifications, open queries, coding decisions and audit trails must all move without loss. If this is your situation, ask the vendor how many transitions it has managed, how it assesses the inherited database, how it handles the outgoing vendor, and how it protects sites from disruption. Ask for a written transition plan before you sign, with a clear point at which responsibility passes.
Ask for the vendor's lock checklist and its typical timeline from last patient visit to database lock. Ask how it plans cleaning throughout the study so that lock does not depend on a final rush.
The table below lists vendors whose profiles name data management in their stated best fit, so you can compare service model, footprint and study coverage before opening individual pages.
| Vendor | Vendor type | Service model | Geography | Study phases | Therapeutic areas |
|---|---|---|---|---|---|
| CTI (Biometrics) | Biometrics / Data Science | TBS | Global (HQ: United States) | Phase I, Phase II, Phase III | Oncology, Rare Diseases, CNS, Cardiovascular |
| Lambda (Biometrics) | Biometrics / Data Science | TBS | Global (HQ: India) | Phase I, Phase II, Phase III, Phase IV | Oncology, Infectious Disease, Diabetes, Cardiovascular |
| Berry Consultants | Biometrics / data science | Biometrics / data science | Global (HQ: Global) | Phase I, Phase II, Phase III, Phase IV | Generalist |
| BioStata | Biometrics / data science | Biometrics / data science | Global (HQ: Global) | Phase I, Phase II, Phase III, Phase IV | Generalist |
| Certara Biometrics | Biometrics / data science | Biometrics / data science | Global (HQ: Global) | Phase I, Phase II, Phase III, Phase IV | Generalist |
| Clindata Insight | Biometrics / Data Science | Specialty biometrics CRO: project, FSP and staffing | Global (HQ: United States) | Phase I, Phase II, Phase III, Phase IV | Oncology, Hematology, Ophthalmology, Dermatology, Respiratory, Immunology, Neurology, Infectious Disease, Cardiovascular, Vaccines |
| Clinical ink Data & Analytics | Biometrics / data science | Biometrics / data science | Global (HQ: Global) | Phase I, Phase II, Phase III, Phase IV | Generalist |
| CluePoints | Biometrics / data science | Biometrics / data science | Global (HQ: Global) | Phase I, Phase II, Phase III, Phase IV | Generalist |
| CRScube Biometrics Services | Biometrics / data science | Biometrics / data science | Global (HQ: Global) | Phase I, Phase II, Phase III, Phase IV | Generalist |
| Cytel | Biometrics / data science | Biometrics / data science | Global (HQ: Global) | Phase I, Phase II | Generalist |
The fields come from each vendor's Clinical Vendor Compare profile. Most of these records describe a combined statistics, programming and data management offer in standard wording, so the table cannot show how deep each data management team is or which EDC systems it uses. A blank or general field means the record is silent. Use the profiles to narrow the field, then test build, cleaning and lock experience directly.
CTI's biometrics record lists a United States headquarters with a global footprint, Phase I to Phase III studies of small and medium scale, and therapeutic coverage in oncology, rare diseases, CNS and cardiovascular medicine. Its stated best fit is sponsors wanting biostatistics consulting alongside data management. Data management fit: relevant if you want one consulting-led team from database to analysis. Ask which EDC systems it builds in and how it resources multinational studies, since its record notes limited global reach.
Lambda's record describes an India-headquartered CRO offering biostatistics, data management and trial services across Phase I to Phase IV, with CDISC standards among its listed strengths. Its stated best fit is cost-conscious sponsors buying data management and biostatistics delivered from India. Data management fit: ask how query handling and site support work across time zones, and who reviews data before key milestones.
Berry Consultants' record describes a focus on adaptive trial design, Bayesian analysis and simulation, with a global footprint, and its stated best fit includes data management among other services. Data management fit: adaptive trials need timely, clean data at each interim decision. Ask whether data management is delivered in-house or through partners, and how data are prepared for interim analyses.
BioStata is listed as a biometrics and data science provider with a global footprint and a generalist remit across Phase I to Phase IV. Its stated best fit covers statistics, programming, data management or analytics. Data management fit: the record does not describe its data management model in detail, so ask for a sample data management plan and the EDC systems it supports.
Certara Biometrics' record lists a global provider covering Phase I to Phase IV with a focus on statistics, programming, data management and analytics. Its record notes it is not aimed at sponsors who want only operational monitoring. Data management fit: ask how its data management team works with its statisticians, and how it handles studies where the EDC system is owned by the sponsor or another vendor.
Clindata Insight's record describes clinical data management and biostatistics for drug development, with a global footprint and a generalist remit. Its stated best fit is sponsors wanting integrated data management and statistics. The profile does not yet list study phases or trial scale. Data management fit: ask for examples of databases it has built and locked, and the systems it uses.
This record lists a biometrics and data science provider with a global footprint across Phase I to Phase IV, focused on statistics, programming, data management and analytics. Data management fit: relevant for studies with substantial electronic source or patient-reported data. Ask how it integrates those data with the clinical database and reconciles them before lock.
CluePoints' record describes a focus on risk-based quality management, anomaly detection using statistical and machine-learning methods, and risk documentation, with a European and global footprint. Data management fit: relevant as a central statistical monitoring layer that looks for unusual patterns across sites, complementing rather than replacing routine data cleaning and query management.
CRScube Biometrics Services is listed as a biometrics and data science provider with a global footprint across Phase I to Phase IV, focused on statistics, programming, data management and analytics. Data management fit: ask whether it builds in its own eClinical systems or in yours, and how data export works at the end of the study.
Cytel's record lists a biometrics and data science provider with a global footprint whose positioning emphasises statistical methodology. The record lists Phase I and Phase II only. Data management fit: if you need data management for a later-phase study, confirm late-phase experience directly, and ask how its data management and statistical teams coordinate.
Data management is commonly bought as a unit-based contract, with fees for database build, per-patient or per-page cleaning, coding, reconciliation and lock; as an FTE or functional service arrangement, where named data managers work in your systems; or inside a full-service CRO contract. EDC licences may be included or charged separately.
The main cost drivers are protocol complexity, the number of forms and edit checks, the number of patients and visits, the volume of external data sources, post-production changes after protocol amendments, and the timeline to lock. Ask how amendments that change the database are priced, what volume of queries is assumed, and whether system licences and hosting are included.
Start in the vendor directory and filter for biometrics and data science to see every listed provider. Open profiles to check stated focus, then place a few side by side on the compare page. If you still need to choose the system itself, read the guide to eClinical and EDC vendors; if you need statistics too, see the guide to biometrics vendors. When your scope is clear, use the sponsor RFP tool to brief vendors on your protocol, data sources and timelines. If you have worked with any of these vendors, please write a review: published reviews are what give the next buyer an evidence base.
Due diligence
Leading vendors in this category combine documented trial experience, therapeutic expertise, robust quality systems, and transparent pricing. Clinical Vendor Compare tracks verified vendor data — experience metrics, review scores, and evidence notes — so sponsors can compare candidates side by side.
Rankings are computed from verified evidence in the CVC vendor dataset: criterion-level scores, platform review scores, public review coverage, and studies managed. No vendor can pay to change a rank; sponsored placements are labelled separately.
The CVC dataset covers hundreds of verified clinical vendors across CRO, technology, and specialist-service categories, each with structured criteria, evidence notes, and source links. Use the compare view on this page to filter by your study needs.
No. Comparison pages, shortlists, and vendor profiles are free for sponsors. Vendors can claim and enhance their profiles, but review data and rankings remain independent.
A data management plan, case report form design and database build in an EDC system, edit checks, user acceptance testing, data cleaning and query management, coding of adverse events and medications, reconciliation of external data such as lab and safety data, and finally a locked database with its documentation. Some vendors also provide the EDC licence; others build in the sponsor’s chosen system.
There is no single right answer. One vendor shortens hand-offs and gives one point of accountability from database to analysis. Separate vendors give independent challenge and let you pick specialists. If you split them, agree data transfer specifications and joint data review meetings from the start so issues are not lost between teams.
In the United States, electronic records and signatures used in clinical investigations fall under 21 CFR Part 11. In the EU, the EMA guideline on computerised systems and electronic data in clinical trials sets expectations for validation, audit trails, access control and data transfers. ICH E6(R3) also expects risk-proportionate data governance across sponsors and service providers.
It depends on protocol complexity, the EDC system, how many integrations are needed and how quickly the sponsor reviews specifications. A vendor working in a familiar system with a library of standard forms will be faster than one building from scratch. Ask for a build timeline tied to a final protocol, with user acceptance testing and go-live dates.
Medical coding maps the free-text terms investigators enter, such as adverse event descriptions and medication names, to standard dictionaries, usually MedDRA for medical terms and WHODrug for medicines. Consistent coding is needed for safety tables and regulatory submissions. Ask who codes, which dictionary versions are used and how coding decisions are reviewed by a physician.
Before lock, all data are entered and cleaned, queries are resolved, coding is complete, external data are reconciled, and investigators sign off their casebooks. A lock checklist confirms each step and access to change data is removed. Ask for the vendor’s checklist and how it handles data that must change after lock.
No, but it complements it. Central statistical monitoring looks across sites and patients for unusual patterns that may indicate errors or misconduct, which standard edit checks cannot catch. ICH E6(R3) encourages this kind of risk-based oversight. Routine data cleaning, query management and reconciliation are still needed.